A new study shows the health consequences of repeat COVID-19 infections, which contribute significant additional risk of adverse health conditions in multiple organ systems, with outcomes including hospitalization and even death.
Scientists recommend masks, vaccines, and vigilance to prevent reinfection.
Since the COVID-19First identified in 2019 in Wuhan, China, Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread globally, resulting in the 2019–20 coronavirus pandemic.” data-gt-translate-attributes=”[{“attribute”:”data-cmtooltip”, “format”:”html”}]”>COVID-19 pandemic began almost three years ago, researchers have discovered that an initial infection can lead to short- and long-term health risks affecting nearly every organ system in the body. They’ve also learned that people can get COVID-19 a second or a third time, despite acquiring natural antibodies after the first infection — even if they’ve had COVID-19 vaccinations and booster shots.
Now, a new research study reveals the health consequences of reinfection. The findings show that repeat SARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the official name of the virus strain that causes coronavirus disease (COVID-19). Previous to this name being adopted, it was commonly referred to as the 2019 novel coronavirus (2019-nCoV), the Wuhan coronavirus, or the Wuhan virus.” data-gt-translate-attributes=”[{“attribute”:”data-cmtooltip”, “format”:”html”}]”>SARS-CoV-2 infections contribute substantial additional risk of adverse health conditions in multiple organ systems.
These outcomes include disorders affecting the heart, lungs, brain, and the body’s blood, musculoskeletal and gastrointestinal systems; hospitalization; and even death. Reinfection also contributes to diabetes, kidney disease, and mental health problems.
The findings, by researchers from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System, were published on November 10 in the journal Nature Medicine.
Ziyad Al-Aly, MD, a clinical epidemiologist at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system, examines data from a new study. Researchers led by Al-Aly found that repeat SARS-CoV-2 infections contribute significant additional risk of adverse health conditions in multiple organ systems. Credit: Washington University School of Medicine
“During the past few months, there’s been an air of invincibility among people who have had COVID-19 or their vaccinations and boosters, and especially among people who have had an infection and also received vaccines; some people started to referring to these individuals as having a sort of superimmunity to the virus,” said senior author Ziyad Al-Aly, MD, a clinical epidemiologist at the Washington University School of Medicine in St. Louis. “Without ambiguity, our research showed that getting an infection a second, third or fourth time contributes to additional health risks in the acute phase, meaning the first 30 days after infection, and in the months beyond, meaning the long COVID phase.”
Additionally, the study indicated that the risk seems to increase with each infection. “This means that even if you’ve had two COVID-19 infections, it’s better to avoid a third,” Al-Aly said. “And if you’ve had three infections, it’s best to avoid the fourth.”
Limiting exposure to the virus is especially important as the U.S. heads into the winter months, with new variants emerging, mutating and already causing an upswing in infections in some parts of the country, Al-Aly said. “People should do their best to prevent repeat infections by masking, for example, getting all of their eligible boosters, staying home when sick. Also, get a flu shot to prevent illness. We really need to do our best to reduce the chance we will have a twin-demic of both COVID-19 and the flu this winter season.”
For this study, the researchers analyzed about 5.8 million de-identified medical records in a database maintained by the U.S. Department of Veterans Affairs, the nation’s largest integrated healthcare system. Patients represented multiple ages, races, and sexes.
The researchers created a controlled data set of 5.3 million people who did not test positive for COVID-19 infection from March 1, 2020, through April 6, 2022. Using the same time frame, the researchers also compiled a control group of more than 443,000 people who had tested positive for one COVID-19 infection, and another group of nearly 41,000 people who had two or more documented infections. Of the latter group, most people had two or three infections, with a small number having had four infections and no one with five or more infections.
Statistical modeling was used to examine the health risks of repeat COVID-19 infections within the first 30 days after contracting the virus and up to six months after.
The study accounted for COVID-19 variants such as delta, omicron, and BA.5. Negative outcomes occurred among the unvaccinated as well as those who had received shots prior to reinfection.
Overall, people with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those with no reinfection, according to the research findings.
In addition, people with repeat infections were 3½ times more likely to develop lung problems, three times more likely to suffer heart conditions, and 1.6 times more likely to experience brain conditions than patients who had been infected with the SARS-CoV-2 virus once.
“Our findings have broad public health implications as they tell us that strategies to prevent or reduce the risk of reinfection should be implemented,” Al-Aly said. “Going into the winter season, people should be aware of the risks and practice vigilance to reduce their risk of infection or reinfection with SARS-CoV-2.”
Reference: “Acute and postacute sequelae associated with SARS-CoV-2 reinfection” by Benjamin Bowe, Yan Xie and Ziyad Al-Aly, 10 November 2022, Nature Medicine.
DOI: 10.1038/s41591-022-02051-3
This research was funded by the U.S. Department of Veterans Affairs; the American Society of Nephrology; and KidneyCure. The data that support the findings of this study are available from the U.S. Department of Veterans Affairs. VA data are made freely available to researchers behind the VA firewall with an approved VA study protocol.
Source: SciTechDaily
